세계
진보 성향
Drugmaker Merck announces approval of new cholesterol-fighting drug
The Guardian World
Lipfendra can be taken in conjunction with or an alternative to statins, the most prescribed medication in the US
Sign up for the Breaking News US newsletter email
The drug giant Merck on Thursday announced it had received FDA approval for a daily pill that can be an alternative to statins for treating high LDL levels, or so-called bad cholesterol. The new pill, Lipfendra, is a version of a drug called a PCSK9 inhibitor.
For decades the go-to therapy to treat high cholesterol levels has been statins, the most prescribed medication in the US. But statins come occasionally with side-effects like muscle aches and they sometimes don’t drop cholesterol levels enough to meet recommended levels.
Continue reading...
이 뉴스, 어떠셨어요?
탭 한 번으로 반응 · 로그인 불필요
같은 사건, 다른 제목
진보 성향 22%중도 성향 44%보수 성향 34%
4건8건6건
진보 성향4
중도 성향8
+4
보수 성향6
+2
기타·국영 1
관련 뉴스 제보는 로그인 후 가능합니다.
'world' 카테고리 뉴스
The Guardian의 다른 기사
Amazon Web Services customers receive bills for up to $1.5tn after global glitch
The Guardian World
Robodebt whistleblower was told her royal commission evidence ‘could cost you your job’, court hears
The Guardian World
Peter Falconio murder: British expert says he has identified a ‘most likely’ burial location
The Guardian World